Primary Mediastinal B-Cell Lymphoma (PMBCL) Latest Advances

Find the Latest Research About Primary Mediastinal B-Cell Lymphoma (PMBCL)

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 388 publications

Extensive Isolated Intracranial Recurrence of Primary Mediastinal B-Cell Lymphoma on FDG PET Imaging.

Extensive Isolated Intracranial Recurrence of Primary Mediastinal B-Cell Lymphoma on FDG PET Imaging.

Journal: Clinical nuclear medicine

Published: March 04, 2026

Primary mediastinal B-cell lymphoma presenting as cardiac tamponade: the importance of a multimodality imaging approach

Primary mediastinal B-cell lymphoma presenting as cardiac tamponade: the importance of a multimodality imaging approach

Journal: Giornale italiano di cardiologia (2006)

Published: February 25, 2026

Correction to "Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry".

Correction to "Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry".

Journal: HemaSphere

Published: February 13, 2026

Lipid Metabolism Reprogramming in Diffuse Large B-Cell Lymphoma (DLBCL): Mechanisms and Treatment Strategies.

Lipid Metabolism Reprogramming in Diffuse Large B-Cell Lymphoma (DLBCL): Mechanisms and Treatment Strategies.

Journal: Cancers

Published: January 04, 2026

Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-R.

Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-R.

Journal: Blood advances

Published: January 02, 2026

Frontline therapy in primary mediastinal B-cell lymphoma: when salvage outcomes redefine the meaning of intensity. Comment on: Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-R.

Frontline therapy in primary mediastinal B-cell lymphoma: when salvage outcomes redefine the meaning of intensity. Comment on: Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-R.

Journal: Haematologica

Published: January 02, 2026

A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.

A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.

Journal: American journal of hematology

Published: December 19, 2025

All shades of gray in the mediastinum: do we have bright ideas about how to diagnose and treat mediastinal gray zone lymphoma in the era of targeted agents?

All shades of gray in the mediastinum: do we have bright ideas about how to diagnose and treat mediastinal gray zone lymphoma in the era of targeted agents?

Journal: Hematology. American Society of Hematology. Education Program

Published: December 05, 2025

On the CHOPping block? Rethinking initial therapy for PMBCL.

On the CHOPping block? Rethinking initial therapy for PMBCL.

Journal: Blood

Published: December 04, 2025

Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL-2020 study in Italy.

Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL-2020 study in Italy.

Journal: British journal of haematology

Published: November 17, 2025

Old methods, lasting impact in relapsed/refractory primary mediastinal B-cell lymphoma.

Old methods, lasting impact in relapsed/refractory primary mediastinal B-cell lymphoma.

Journal: Haematologica

Published: November 02, 2025

Mediastinal Gray Zone Lymphomas: Diagnostic Challenges, Clinicopathologic Overlap, and Emerging Management Strategies.

Mediastinal Gray Zone Lymphomas: Diagnostic Challenges, Clinicopathologic Overlap, and Emerging Management Strategies.

Journal: Hematology reports

Published: October 31, 2025

Showing 1-12 of 388

Last Updated: 04/28/2026